Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354913
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2006-07-19
Brief Title:
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Sponsor:
Duke University
Organization:
Duke University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gliosarcoma |
| Glioblastoma |
Keywords:
| Name | View |
|---|---|
| Meningioma | View |
| adult grade I meningioma | View |
| adult grade II meningioma | View |
| adult grade III meningioma | View |
| adult papillary meningioma | View |
| adult anaplastic meningioma | View |
| recurrent adult brain tumor | View |
| glioblastoma multiforme GBM | View |
| Imatinib | View |
| Imatinib mesylate | View |
| Hydroxyurea | View |
| Droxia | View |
| Hydrea | View |
| Hydroxycarbamide | View |
| Gleevec | View |